Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
168M
-
Shares change
-
-330K
-
Total reported value, excl. options
-
$261M
-
Value change
-
-$3.53M
-
Number of buys
-
37
-
Number of sells
-
-54
-
Price
-
$1.55
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q1 2025
118 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q1 2025.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 168M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (27.1M shares), Blackstone Inc. (20.5M shares), Deep Track Capital, LP (17.8M shares), Syncona Portfolio Ltd (16.6M shares), ARMISTICE CAPITAL, LLC (11M shares), FMR LLC (10.2M shares), Avoro Capital Advisors LLC (9.91M shares), TFG Asset Management GP Ltd (8.6M shares), Frazier Life Sciences Management, L.P. (4.62M shares), and BlackRock, Inc. (3.94M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.